Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Trial of Citalopram for the Prevention of Depression
This study is currently recruiting participants.
Study NCT00317746 Information provided by McGill University Health Center
First Received: April 21, 2006 Last Updated: July 17, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Depression
HIV Infections
Hepatitis C
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Communicable Diseases
Depressive Disorder
Hepatitis
Infection
More general conditions related to this trial
Behavioral Symptoms
Digestive System Diseases
Flaviviridae Infections
Hepatitis, Viral, Human
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Liver Diseases
Mental Disorders
Mood Disorders
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
Citalopram
Placebo
Additional drug interventions recognized in this trial
Dexetimide
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antiparkinson Agents
Autonomic Agents
Central Nervous System Agents
Cholinergic Agents
Cholinergic Antagonists
Molecular Mechanisms of Pharmacological Action
Muscarinic Antagonists
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Parasympatholytics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
McGill University Health Center
Ontario HIV Treatment Network
Schering Canada, Inc.
Canadian HIV Trials Network
Back to top of Main Content